title: Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study.
authors.forename: T C
authors.initials: TC
authors.lastname: Van Holten
authors.forename: M
authors.initials: M
authors.lastname: Roest
authors.forename: J
authors.initials: J
authors.lastname: Riphagen
authors.forename: C
authors.initials: C
authors.lastname: Jansen
authors.forename: P
authors.initials: P
authors.lastname: Naarding
authors.forename: H J
authors.initials: HJ
authors.lastname: Adriaansen
authors.forename: P G
authors.initials: PG
authors.lastname: De Groot
authors.forename: J A
authors.initials: JA
authors.lastname: Remijn
mesh_terms: D000328:Adult; D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D016022:Case-Control Studies; D015283:Citalopram / Q000627:therapeutic use*; D015536:Down-Regulation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D019007:P-Selectin / Q000378:metabolism; D017374:Paroxetine / Q000627:therapeutic use*; D010979:Platelet Function Tests; D012701:Serotonin / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram; D019007:P-Selectin; D017374:Paroxetine; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; C546937:SELP protein, human